(2) | (47) | " (5) | # (2) | $ (1) | 0 (43) | 1 (528) | 2 (598) | 3 (345) | 4 (27) | 5 (21) | 6 (14) | 7 (7) | 8 (3) | 9 (4) | < (49) | A (336) | B (71) | C (270) | D (140) | E (194) | F (157) | G (462) | H (72) | I (178) | J (46) | K (72) | L (87) | M (209) | N (154) | O (62) | P (276) | Q (10) | R (113) | S (501) | T (561) | U (134) | V (38) | W (308) | X (9) | Y (15) | Z (8) |   (1) | Д (1) | П (1) | С (1) | إ (1) | ‘ (2) | “ (1)
Title Last update
33rd Stop TB Board Decision Points Wed, 01/25/2023 - 04:21
33-9.3_GFstrategydevelopment_2020openconsultationpdf_presentation_en Wed, 01/25/2023 - 04:59
33-9.2_GFcovid19_mitigatingimpact_report_en Wed, 01/25/2023 - 04:59
33-9.1_GFcorporate_2020resultsreport_report_en Wed, 01/25/2023 - 04:59
33-6.2 The Impact of COVID on TB Response A Community Perspective Wed, 01/25/2023 - 04:57
33-6.1 STP UNHLM CRG Report_17 Nov 2020 Wed, 01/25/2023 - 04:56
33-5.4 Information note on Digital Health technologies for TB during the Covid-19 pandemic Wed, 01/25/2023 - 04:55
33-5.3 Rapid information note on selection of SARS-CoV-2 diagnostics Wed, 01/25/2023 - 04:55
33-5.2 Modelling study attention to TB during the Covid-19 pandemic Wed, 01/25/2023 - 04:54
33-5.1 Covid PPT_Board Nov 2020 for LD Wed, 01/25/2023 - 04:54
33-4.6 Global Plan 2023-2030 development - STP Board Nov 2020 Wed, 01/25/2023 - 05:21
33-4.4_FinancingTBresponse_BambooCapital Wed, 01/25/2023 - 04:42
33-4.2 UNHLM financing targets for countries Wed, 01/25/2023 - 04:41
33-4.1 Global Plan – incl. resource needs for implementation and research Wed, 01/25/2023 - 04:40
33-3.2 2020 UNSG Report on TB Wed, 01/25/2023 - 04:39
33-3.1 UNHLM_Targets&Commitments Wed, 01/25/2023 - 04:39
33-3.1 Targets - Stop TB Board Nov 2020 Wed, 01/25/2023 - 04:38
33-2.3 Stop TB Partnership preliminary KPI Results 2020 Wed, 01/25/2023 - 04:37
33-2.2 Stop TB Partnership KPI Results 2019_updated&final Wed, 01/25/2023 - 04:36
33-2.1 Report of the Executive Director Wed, 01/25/2023 - 04:30
33-13.6 TB REACH Presentation Wed, 01/25/2023 - 05:19
33-13.5 IDP screening for TB and HIV in Nigeria Wed, 01/25/2023 - 05:18
33-13.4 Wave 9 Concept Note Wed, 01/25/2023 - 05:18
33-13.3 Perspectives on TB REACH in the Asia-Pacific Region Wed, 01/25/2023 - 05:17
33-13.2 Costing analysis for Wave 5 projects Wed, 01/25/2023 - 05:17
33-13.1 2020 Updated TB REACH 3.0 Concept Wed, 01/25/2023 - 05:07
33-10.3 STP Board Proposed Action Plan 112020 Wed, 01/25/2023 - 05:01
33-10.2 PWC Staff Pulse Survey - Summary deck of topline findings Wed, 01/25/2023 - 05:01
33-10.1 Independent Review Findings Wed, 01/25/2023 - 05:01
33-1.2 Report on Actions of DPs_32nd Board meeting Wed, 01/25/2023 - 04:28
33-1.1 Draft Agenda 20Nov Wed, 01/25/2023 - 04:27
33-0.3 List of Participants_20 November 2020 Wed, 01/25/2023 - 04:24
33-0.2 List of Documents Wed, 01/25/2023 - 04:23
33-0.1 Virtual Guidance Note Wed, 01/25/2023 - 04:23
32-9.1 Global Drug Facility_Presentation [.pdf] Fri, 01/27/2023 - 04:38
32-9-2.9 Model Service Level Agreement for Xpert Surcharges v1 [.pdf] Fri, 01/27/2023 - 04:45